SOM Biotech will attend the 12th Annual Global Discovery to Development Innovation Forum (GDDIF)

posted on May 8, 2019
Dr. Luca Signorile, Senior computational chemist at SOM Biotech, will be attending the 12th Annual Global Discovery to Development Innovation Forum (GDDIF) that will take place in Amsterdam on 14th – 15th of May. The Annual GDDIF is the leading pharmaceutical Research & Development summit for pharma decision makers, scientific leaders, and solutions experts. Taking a…
continue reading →

SOM Biotech at TechShare – pre-IPO programme launched by Euronext

posted on May 8, 2019
Dr. Raúl Insa, SOM Biotech CEO, attended the second campus of the 2018-2019 TechShare programme organized by Euronext and Nova School of Business and Economics (Nova SBE). The event took place on 15th and 16th of March in Lisbon, Portugal. TechShare is an educational and mentoring programme which aims to familiarize the CEOs of Bio-Tech companies with the financial markets.…
continue reading →

3rd Annual Clinical Trials Summit (CTS) 2019

posted on April 27, 2019
Dr. Santiago Esteva, Head of Clinical Operations at SOM Biotech, will be presenting at the 3rd Annual Clinical Trials Summit that will take place in Barcelona next April 29 and 30. He will be discussing about the relationship of small biotech companies and CROs from SOM’s perspective, highlighting the challenges in selecting a CRO to conduct the…
continue reading →

SOMCT02 Huntington’s disease trial recruits 100% of patient target

posted on March 18, 2019
On March 8, 2019, the SOMCT02 clinical trial successfully closed recruitment, marking 100% fulfillment of its targeted number of patients. SOM Biotech is very proud of all the efforts being done by the participating sites, and we are expecting to achieve good results from this clinical trial which will cover a great medical need in…
continue reading →

SOM Biotech closes a financing round of 7M Euros

posted on March 8, 2019
SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network. Several of the current partners of SOM Biotech have also taken the…
continue reading →

Rare Disease Day 2019

posted on February 28, 2019
Today, February 28th, is Rare Disease Day, and SOM Biotech is one with Eurordis in raising awareness of rare diseases through the #ShowYourRare campaign. SOM Biotech Team Rare Disease Day is the international awareness-raising campaign for rare diseases and is celebrated on the last day of February each year. Since Rare Disease Day started in 2008, thousands of…
continue reading →